EquityFlow
›
Companies
› CV6 Therapeutics
CV6 Therapeutics
Biotech
· Belfast, GB ·
cv6therapeutics.com
Belfast biotech developing the anti-cancer drug CV6-168.
Funding history
Date
Round
Amount
Nov 2022
Funding round
Belfast biotech CV6 Therapeutics raised £8m (incl. a £3m Invest NI grant) from QUBIS, Techstart and Clarendon to trial its cancer drug.
$9.6M
Investors
Clarendon Fund Managers
Invest NI
QUBIS
Techstart Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →